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The P2Y2 nucleotide receptor is a Go/q coupled receptor that is activated 
equipotently by extracellular nucleotides such as ATP or UTP and is 
upregulated in a variety of tissues in response to injury or stress. The 
biological effects of extracellular nucleotides are mediated through 
activation of P1 and P2 purinergic receptors. P1 receptors are responsive to 
adenine and P2 receptors are activated by a variety of nucleotides including 
ATP and UTP. The P2 receptors are subdivided into two distinct categories, 
the ionotropic ligand-gated channel (P2X) receptors and G-protein coupled 
P2Y-receptors, with seven transmembrane domains. Previous studies have shown 
that the human P2Y2 nucleotide receptor contains an arginine-glycine-aspartic 
acid (RGD), integrin-binding domain.  This domain is located in the first 
extracellular loop of the receptor and binds specifically to the αvβ3/β5 group 
of integrins. The P2Y2 receptor interacts with the αv integrins by the RGD 
domain to activate Go and induce cell migration. The human and murine P2Y2R’s 
have the RGD integrin-binding domain, whereas the rat homologue has a QGD 
domain. However, this change in the arginine position in the RGD integrin-
binding domain is considered to be a conservative substitution that maintains 
integrin binding.  In order to confirm this assumption we changed the RGD 
domain of the human P2Y2 receptor into the QGD domain by in vitro mutagenesis. 
The wild-type and the QGD mutant P2Y2 receptors were transiently transfected 
into P2 receptor null, 1321 N1 astrocytoma cell line. Preliminary data 
suggest that the QGD mutant can stimulate PLC dependent intracellular Ca2+ 
mobilization and also activate cofillin and extracellular signal-regulated 
kinases (Erk) with equal efficacy and agonist potency as the wild type 
receptor. Further tests need to be done to verify that integrin bindin and 
signaling by the Rac and Rho pathways remain unaffected in the QGD mutant to 
induce integrin dependent cell migration in response to UTP and ATP. 
